Innoviva Strategic Opportunities LLC, Director, 10% Owner at Armata Pharmaceuticals, Inc. (ARMP), bought 2,424,244 shares at $3.30 ($8.0M) on 2021-10-29, disclosed to the SEC on 2021-11-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.30 | 1,212,122 | $4.0M | 50.0% |
| 2 | $3.30 | 1,212,122 | $4.0M | 50.0% |
| Total | $3.30 avg | 2,424,244 | $8.0M | 100% |
| Filing → |
| ETTX | BUY | 2021-06-11 | $12.5M | — | Filing → |
| ARMP | BUY | 2021-01-28 | $6.1M | — | Filing → |